SHARE PURCHASE AGREEMENT among Liminal BioSciences Inc. as Purchaser - and - The Royal Institution for the Advancement of Learning/McGill University, AMORCHEM, LIMITED PARTNERSHIP, Genesys Ventures III LP - and - MSBI Valorisation Inc. as Sellers -...Share Purchase Agreement • September 14th, 2020 • Liminal BioSciences Inc. • Pharmaceutical preparations
Share Purchase Agreement dated July 17, 2020 among Fairhaven Pharmaceuticals Inc. (the "Corporation"), Liminal BioSciences Inc. ("Purchaser"), The Royal Institution for the Advancement of Learning/McGill University (“McGill”), AMORCHEM, LIMITED PARTNERSHIP ("AmorChem LP"), Genesys Ventures III LP ("Genesys") and MSBI Valorisation Inc. (“MSBI”) (collectively, the "Sellers"), and each of Elizabeth Douville and Jamie Stiff solely in their capacity as the Agents (as defined below) on behalf of the Sellers, and to which intervenes AmorChem Holdings Inc., solely for purposes of Section 11.6 (Terminated Agreements).
